EPO and anemia (phenotype): Achieving guidelines goals for anemia management has been challenging in this population in large part due to the practice of addressing the erythropoietin dosing monthly while recognizing that the RBC lifespan is 90 days, creating a disconnect between prescription and outcome assessment.